Melina Carlos Tovar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Melina Carlos Tovar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Blanco Silva
Instituto Mexicano del Seguro Social, Critical Medicine Department, Ciudad de México-México
1 shared publication - Carlos Alfredo Almazan Hernandez
Universidad Tominaga Nakamoto, Contemporary Medical Education. Naucalpan de Juárez, Estado de México, México
1 shared publication - Cesar Augusto Flores Dueñas
Instituto de Investigaciones en Ciencias Veterinarias, Universidad Autónoma de Baja California
1 shared publication - Claudio Sandoval
Universidad Cientifica del Sur, Rheumatology, Lima Peru
1 shared publication - Felipe Eduardo Macías Prado
Hospital Alfredo Paulson
1 shared publication - Javier Ignacio Soto Espinoza
Universidad San Sebastián, Medical Department, Santiago de Chile, Chile
1 shared publication
Latest Publications
- Open Access
- 2 September 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 2087
Impact of mechanical circulatory support modalities on outcomes in acute myocardial infarction-related cardiogenic shock undergoing early revascularization: A systematic review of survival and cardiac function outcomes
Introduction: Cardiogenic shock complicates 5–10% of acute myocardial infarctions and remains associated with early mortality of approximately 40%. Mechanical circulatory support devices, including intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation, are increasingly applied, yet their effect on outcomes is uncertain. Objectives: This review aimed to systematically evaluate the impact of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation on survival and left ventricular function in patients with acute myocardial infarction complicated by cardiogenic shock undergoing early revascularization. Methods: A systematic search of PubMed, ScienceDirect, and the Cochrane Library was conducted up to May 1, 2025. Eligible studies included randomized controlled trials and observational studies assessing intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction–related cardiogenic shock. Two reviewers independently screened studies, extracted data, and assessed quality using Cochrane RoB 2.0 and ROBINS-I tools. Sixteen studies encompassing more than 35,000 patients were included. Results: Across all modalities, mechanical circulatory support did not consistently improve short- or long-term survival. Randomized trials showed no benefit for intra-aortic balloon pump in survival or ventricular recovery. Impella use was associated with higher rates of bleeding and vascular complications without mortality advantage. Extracorporeal membrane oxygenation demonstrated the highest complication rates. Early Impella deployment showed limited potential for ventricular recovery in select cases, but results were inconsistent. Conclusions: Despite theoretical hemodynamic benefits, current evidence does not demonstrate consistent improvements in survival or left ventricular function with intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction complicated by cardiogenic shock. High complication rates, particularly with Impella and extracorporeal membrane oxygenation, offset potential benefits, underscoring the need for timely revascularization rather than reliance on mechanical circulatory support.
- 2 September 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 2087
Open AccessImpact of mechanical circulatory support modalities on outcomes in acute myocardial infarction-related cardiogenic shock undergoing early revascularization: A systematic review of survival and cardiac function outcomes
Introduction: Cardiogenic shock complicates 5–10% of acute myocardial infarctions and remains associated with early mortality of approximately 40%. Mechanical circulatory support devices, including intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation, are increasingly applied, yet their effect on outcomes is uncertain. Objectives: This review aimed to systematically evaluate the impact of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation on survival and left ventricular function in patients with acute myocardial infarction complicated by cardiogenic shock undergoing early revascularization. Methods: A systematic search of PubMed, ScienceDirect, and the Cochrane Library was conducted up to May 1, 2025. Eligible studies included randomized controlled trials and observational studies assessing intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction–related cardiogenic shock. Two reviewers independently screened studies, extracted data, and assessed quality using Cochrane RoB 2.0 and ROBINS-I tools. Sixteen studies encompassing more than 35,000 patients were included. Results: Across all modalities, mechanical circulatory support did not consistently improve short- or long-term survival. Randomized trials showed no benefit for intra-aortic balloon pump in survival or ventricular recovery. Impella use was associated with higher rates of bleeding and vascular complications without mortality advantage. Extracorporeal membrane oxygenation demonstrated the highest complication rates. Early Impella deployment showed limited potential for ventricular recovery in select cases, but results were inconsistent. Conclusions: Despite theoretical hemodynamic benefits, current evidence does not demonstrate consistent improvements in survival or left ventricular function with intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction complicated by cardiogenic shock. High complication rates, particularly with Impella and extracorporeal membrane oxygenation, offset potential benefits, underscoring the need for timely revascularization rather than reliance on mechanical circulatory support.
- Open Access
- 1 August 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1955
Impact of Extracorporeal Membrane Oxygenation (ECMO) in Patients with Refractory Cardiogenic Shock: Analysis of Mortality and Hemodynamic Recovery - A Systematic Review
Introduction: Extracorporeal membrane oxygenation (ECMO) is an advanced life support for critically ill patients with refractory cardiogenic shock. However, evidence on its impact on mortality, hemodynamic recovery, and complications remains heterogeneous. This review aims to systematically evaluate ECMO’s impact on mortality and hemodynamic recovery in adult patients with refractory cardiogenic shock, addressing gaps and variations in existing literature.Material and Methods: This systematic review followed PRISMA guidelines. Databases searched were PubMed, Cochrane Library, and Google Scholar. Two reviewers independently selected studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale. Findings were synthesized narratively due to study heterogeneity.Results: Mortality rates ranged widely from 33 to 75%, reflecting differences in patient populations and timing of ECMO initiation. Early ECMO initiation within less than one hour of shock onset was associated with a 47 percent reduction in mortality risk. In-hospital mortality was approximately 40%, increasing to nearly 60% at one-year follow-up. Success rates for weaning patients off ECMO varied between 53% and 88%. Hemodynamic improvements following ECMO support included increased blood pressure, improved left ventricular ejection fraction, and decreased serum lactate levels. Complications were frequent and diverse, predominantly bleeding, stroke, renal failure, and limb ischemia. Bleeding complications are strongly correlated with mortality.Conclusions: ECMO provides crucial circulatory support in refractory cardiogenic shock, improving hemodynamic parameters but with persistently high mortality and complication rates. Early initiation and careful patient selection are vital for optimizing outcomes, underscoring the need for multidisciplinary management and further high-quality prospective studies.
- 1 August 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1955
Open AccessImpact of Extracorporeal Membrane Oxygenation (ECMO) in Patients with Refractory Cardiogenic Shock: Analysis of Mortality and Hemodynamic Recovery - A Systematic Review
Introduction: Extracorporeal membrane oxygenation (ECMO) is an advanced life support for critically ill patients with refractory cardiogenic shock. However, evidence on its impact on mortality, hemodynamic recovery, and complications remains heterogeneous. This review aims to systematically evaluate ECMO’s impact on mortality and hemodynamic recovery in adult patients with refractory cardiogenic shock, addressing gaps and variations in existing literature.Material and Methods: This systematic review followed PRISMA guidelines. Databases searched were PubMed, Cochrane Library, and Google Scholar. Two reviewers independently selected studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale. Findings were synthesized narratively due to study heterogeneity.Results: Mortality rates ranged widely from 33 to 75%, reflecting differences in patient populations and timing of ECMO initiation. Early ECMO initiation within less than one hour of shock onset was associated with a 47 percent reduction in mortality risk. In-hospital mortality was approximately 40%, increasing to nearly 60% at one-year follow-up. Success rates for weaning patients off ECMO varied between 53% and 88%. Hemodynamic improvements following ECMO support included increased blood pressure, improved left ventricular ejection fraction, and decreased serum lactate levels. Complications were frequent and diverse, predominantly bleeding, stroke, renal failure, and limb ischemia. Bleeding complications are strongly correlated with mortality.Conclusions: ECMO provides crucial circulatory support in refractory cardiogenic shock, improving hemodynamic parameters but with persistently high mortality and complication rates. Early initiation and careful patient selection are vital for optimizing outcomes, underscoring the need for multidisciplinary management and further high-quality prospective studies.